SLN

#2809
Silence Therapeutics Plc - American Depository Share
6.9 0 USD
+0.44%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
6.90
6.90
Intervallo Annuale
4.19
8.40
Variazione giornaliera
+0.44%
Variazione Mensile
-4.43%
Variazione di 6 mesi
+4.07%
Variazione Annuale
+14.24%
Chiusura Precedente
6.8 7
Open
6.9 0
Minimo
6.9 0
High
6.9 0
Volume
29
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 325.92 M
  • Employee 88
  • Founded 1994
  • CEO Craig A Tooman
  • Website www.silence-therapeutics.com
  • Headquarter United Kingdom
  • FIGI BBG00WVTHPN2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-9.65
Rapporto prezzo/fatturato
1 541.15

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

Notizie